☆ 4.8 Article

Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19

FRONTIERS IN IMMUNOLOGY (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Virology

The cytokine storm and COVID-19

Biying Hu et al.

Summary: COVID-19, caused by SARS-CoV-2, has become a global pandemic since its emergence in Wuhan, China, in December 2019, posing a serious threat to public health. Close contact and respiratory droplets are the main modes of transmission. The cytokine storm is closely associated with disease severity and mortality, emphasizing the importance of studying and treating the cytokine storm in COVID-19.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Article Immunology

Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients

Tamara S. Rodrigues et al.

Summary: The active NLRP3 inflammasome in response to SARS-CoV-2 infection is associated with disease severity in COVID-19 patients, with higher levels of IL-18 and Casp1p20 correlating with poor clinical outcomes. These findings suggest that inflammasomes may serve as markers of disease severity and potential therapeutic targets for COVID-19.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

添加到收藏夹

Article Immunology

Cytokine Storm in Coronavirus Disease 2019 and Adult-Onset Still's Disease: Similarities and Differences

Jianfen Meng et al.

Summary: This study compared the cytokine and ferritin levels between severe COVID-19 and active AOSD patients, revealing significant differences in IL-6, IL-10, and ferritin levels, laying the groundwork for developing therapeutic strategies targeting the hyperinflammatory process in COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Rheumatology

Immune cartography of macrophage activation syndrome in the COVID-19 era

Dennis McGonagle et al.

Summary: This article discusses macrophage activation syndrome (MAS) in relation to other cytokine storm scenarios, providing a framework for understanding MAS within the spectrum of innate and adaptive immunity in the context of gain or loss of immune function.

NATURE REVIEWS RHEUMATOLOGY (2021)

添加到收藏夹

Review Immunology

Cytokine Storm: The Primary Determinant for the Pathophysiological Evolution of COVID-19 Deterioration

Ruirong Chen et al.

Summary: The COVID-19 pandemic poses a major threat to global health, with cytokine storms being a significant cause of disease deterioration and death, making it crucial to understand the pathophysiological processes involved for effective treatment.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!

Francesca Coperchini et al.

Summary: SARS-COV-2 virus leads to a devastating pandemic, with cytokine-storm being a peculiar aspect of infection causing severe respiratory damage and multi-organ failure. IL-6, CXCL10, and macrophages play critical roles in the aberrant immune response, highlighting the importance of their interplay in the onset and progression of the cytokine storm in COVID-19.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

Profile of Circulatory Cytokines and Chemokines in Human Coronaviruses: A Systematic Review and Meta-Analysis

Ayat Zawawi et al.

Summary: This study evaluated the inflammatory cytokine profile associated with MERS-CoV, SARS-CoV, and SARS-CoV-2. The results suggest that a high level of circulating IL-6 could be associated with the severity of infection of these three coronavirus strains. The findings highlight the potential use of IL-6 as a therapeutic target to improve outcomes in severe cases.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Medicine, General & Internal

Interleukin-6 blocking agents for treating COVID-19: a living systematic review

Lina Ghosn et al.

Summary: IL-6 blocking agents have been used for treating severe COVID-19, with tocilizumab showing reduced all-cause mortality and possibly fewer serious adverse events at day 28. The efficacy of sarilumab remains uncertain, with more evidence needed to determine its effects on mortality and adverse events.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Immunopathogenesis and treatment of cytokine storm in COVID-19

Jae Seok Kim et al.

Summary: Severe COVID-19 is characterized by systemic hyper-inflammation and cytokine storm, often leading to acute respiratory distress syndrome and multiple organ failure. Treatment of COVID-19 cytokine storm is crucial, with anti-inflammatory therapies playing a significant role. Various approaches are being used, including new cytokine-targeted therapies, to address the cytokine storm associated with COVID-19.

THERANOSTICS (2021)

添加到收藏夹

Article Rheumatology

Elevated plasma galectin-3 levels and their correlation with disease activity in adult-onset Still's disease

Po-Ku Chen et al.

CLINICAL RHEUMATOLOGY (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

Chaolin Huang et al.

LANCET (2020)

添加到收藏夹

Letter Rheumatology

Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander?

Piero Ruscitti et al.

ANNALS OF THE RHEUMATIC DISEASES (2020)

添加到收藏夹

Review Immunology

Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy

Paola Toniati et al.

AUTOIMMUNITY REVIEWS (2020)

添加到收藏夹

Review Immunology

COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?

Serena Colafrancesco et al.

AUTOIMMUNITY REVIEWS (2020)

添加到收藏夹

Article Medicine, General & Internal

Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study

Yan Deng et al.

CHINESE MEDICAL JOURNAL (2020)

添加到收藏夹

Article Immunology

Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience

Ying Sun et al.

JOURNAL OF AUTOIMMUNITY (2020)

添加到收藏夹

Review Immunology

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies

Yujun Tang et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Immunology

Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper

Sonu Bhaskar et al.

FRONTIERS IN IMMUNOLOGY (2020)

添加到收藏夹

Article Medicine, Research & Experimental

Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and RANTES with mild disease

Yan Zhao et al.

JCI INSIGHT (2020)

添加到收藏夹

Review Cell Biology

Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts

Jin Wang et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia

Sara De Biasi et al.

NATURE COMMUNICATIONS (2020)

添加到收藏夹

Article Rheumatology

Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study

Giulio Cavalli et al.

LANCET RHEUMATOLOGY (2020)

添加到收藏夹

Article Rheumatology

Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis

Tomohiro Koga et al.

ARTHRITIS RESEARCH & THERAPY (2020)

添加到收藏夹

Article Rheumatology

Elevated serum levels of checkpoint molecules in patients with adult Still's disease

Yuya Fujita et al.

ARTHRITIS RESEARCH & THERAPY (2020)

添加到收藏夹

Article Rheumatology

Neutrophil Extracellular Traps May Contribute to the Pathogenesis in Adult-onset Still Disease

Mi-Hyun Ahn et al.

JOURNAL OF RHEUMATOLOGY (2019)

添加到收藏夹

Article Rheumatology

Comparative study of Interleukin-18 (IL-18) serum levels in adult onset Still's disease (AOSD) and systemic onset juvenile idiopathic arthritis (sJIA) and its use as a biomarker for diagnosis and evaluation of disease activity

Holger Kudela et al.

BMC RHEUMATOLOGY (2019)

添加到收藏夹

Article Rheumatology

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease

Cem Gabay et al.

ANNALS OF THE RHEUMATIC DISEASES (2018)

添加到收藏夹

Article Rheumatology

Efficacy and safety of tocilizumab with inhibition of interleukin-6 in adult-onset Still's disease: A meta-analysis

Yubo Ma et al.

MODERN RHEUMATOLOGY (2018)

添加到收藏夹

Review Rheumatology

Mechanisms, biomarkers and targets for adult-onset Still's disease

Eugen Feist et al.

NATURE REVIEWS RHEUMATOLOGY (2018)

添加到收藏夹

Article Rheumatology

Elevated Expression of the NLRP3 Inflammasome and Its Correlation with Disease Activity in Adult-onset Still Disease

Chia-Wei Hsieh et al.

JOURNAL OF RHEUMATOLOGY (2017)

添加到收藏夹

Review Rheumatology

Macrophage activation syndrome complicating adult onset Still's disease: A single center case series and comparison with literature

Aleksander Lenert et al.

SEMINARS IN ARTHRITIS AND RHEUMATISM (2016)

添加到收藏夹

Review Microbiology

IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections

Jeroen Slaats et al.

PLOS PATHOGENS (2016)

添加到收藏夹

Review Medicine, General & Internal

Adult-onset Still's disease-pathogenesis, clinical manifestations, and new treatment options

Sabeeda Kadavath et al.

ANNALS OF MEDICINE (2015)

添加到收藏夹

Review Immunology

Seizing the clinical presentation in adult onset Still's disease. An extensive literature review

Neha Narula et al.

AUTOIMMUNITY REVIEWS (2015)

添加到收藏夹

Article Rheumatology

Efficacy of Tocilizumab in Conventional Treatment-Refractory Adult-Onset Still's Disease

Francisco Ortiz-Sanjuan et al.

ARTHRITIS & RHEUMATOLOGY (2014)

添加到收藏夹

Article Infectious Diseases

Circulating galectin-3 in infections and non-infectious inflammatory diseases

J. ten Oever et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2013)

添加到收藏夹

Article Rheumatology

Beneficial Effect of Interleukin 1 Inhibition with Anakinra in Adult-onset Still's Disease. An Open, Randomized, Multicenter Study

Dan Nordstrom et al.

JOURNAL OF RHEUMATOLOGY (2012)

添加到收藏夹

Article Rheumatology

Clinical Manifestations but not Cytokine Profiles Differentiate Adult-onset Still's Disease and Sepsis

Monika Rau et al.

JOURNAL OF RHEUMATOLOGY (2010)

添加到收藏夹

Article Rheumatology

Potential role of Th17 cells in the pathogenesis of adult-onset Still's disease

Der-Yuan Chen et al.

RHEUMATOLOGY (2010)

添加到收藏夹

Article Immunology

The immunological potential of galectin-1 and-3

Amy Dhirapong et al.

AUTOIMMUNITY REVIEWS (2009)

添加到收藏夹

Review Immunology

Galectins in innate immunity: dual functions of host soluble β-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs)

Sachiko Sato et al.

IMMUNOLOGICAL REVIEWS (2009)

添加到收藏夹

Review Immunology

The regulation of inflammation by galectin-3

Neil C. Henderson et al.

IMMUNOLOGICAL REVIEWS (2009)

添加到收藏夹

Article Immunology

Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis

Masako Seki et al.

CLINICAL IMMUNOLOGY (2008)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.